EGFR and glioblastoma: IDH wild-type glioma frequently exists other molecular alterations, such as epidermal growth factor receptor amplification and telomerase reverse transcriptase promoter mutation, which makes them much more similar to glioblastoma.[11] The BTG patients ranged in age from 3 months to 80 years.[12,13] There is a wide spectrum of clinical presentations in patients with AA including focal neurological deficits, headache, speech disorders, dementia, gait disturbances, seizures, which correspond to the location of the tumor.